Please join us for a special lecture on photoimmunotherapy, a new type of molecular targeted cancer therapy developed by Professor Hisataka Kobayashi and his colleagues at the National Cancer Institute (NCI).
Using fluorescent dye with cancer-specific antibodies, scientists at NCI have discovered how to use near-infrared light to burn holes in cancer cells without harming surrounding tissue. On May 11, Professor Hisataka Kobayashi will present this new development in the fight against cancer, examining the science behind the technique, its applications, and the future of cancer treatment.
About NCI's Molecular Imaging Program
The goal of the Molecular Imaging Program (MIP) is to develop targeted imaging methods that accelerate the development of cancer therapies. The MIP is focused on the development and translation of in vivo molecular imaging agents for early detection and monitoring. Given the high risks and high costs of conducting research in this field, the MIP is well positioned to address challenges that the field of molecular imaging faces. More information is available on NCI's website.
This event is free and open to the public, but registration is required for security purposes. Doors open at 1:30 PM. Registered guests will be seated on a first come, first served basis. Please note that seating is limited and registration does not guarantee guests a seat.
To modify your registration, please email email@example.com. Your registration is not transferable.